Skip to main content
Completed Clinical Trials

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

By April 24, 2017No Comments

Condition

Lung Cancer|Malignant Mesothelioma

Estimated Enrollment: 20

Age Group: 20 Years to 70 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Primary Purpose: Treatment

Study ID Numbers: CDR0000067177|RPCI-DS-96-25

Study First Received: November 1, 1999

Last Updated: March 3, 2011

Estimated Primary Completion Date: June 1998

 

Primary Outcome Measures:

Sponsors and Collaborators:

Roswell Park Cancer Institute

Website Link: https://ClinicalTrials.gov/show/NCT00003974

Leave a Reply